All posts in
New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK
“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec
Biotech Targeting Tau-Tangles in Neurodegeneration Initiates Clinical Trials
Where Others Failed, a Vaccine for Dementia Shows Potential in the Clinic
Roche lands FDA Approval for the Best Multiple Sclerosis Drug Yet
A New Parkinson’s Drug from Italy just got FDA Approval!
Galapagos finds a Partner to Boost its Pipeline with Drug Combinations
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
This Spanish Biotech is Detecting Alzheimer’s before Symptoms Appear
Resetting the Immune System to Stop Multiple Sclerosis
French Biotech bids for Crowdfunding in Neurodegenerative Disease
Biotech from the Bermuda Islands Brings Good News for Dementia Patients
Labiotech UG, All Rights Reserved -
Send this to friend